CAH — CARDINAL HEALTH INC

NYSE · Consumer Discretionary · Distributors · CIK 721371 ·
Last close
$228.91
Market Cap
$53.61B
52W High
$229.78
52W Low
$180.45
ADV30
2,429,945
Next earnings
2026-04-30
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 60,940,000,000 2,498,000,000 842,000,000 399,000,000 56,689,000,000 3,937,000,000 59,361,000,000
Dec 2025 65,627,000,000 2,397,000,000 763,000,000 467,000,000 58,083,000,000 2,777,000,000 60,783,000,000
Sep 2025 64,009,000,000 2,319,000,000 754,000,000 450,000,000 55,228,000,000 4,593,000,000 57,959,000,000
Jun 2025 60,159,000,000 2,202,000,000 585,000,000 239,000,000 53,122,000,000 3,874,000,000 55,756,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$5,009,000,000
Investing CF
$-3,934,000,000
Financing CF
$-456,000,000
CapEx
$-617,000,000
Dividends Paid
$-491,000,000
Buybacks
$-1,008,000,000
EPS Diluted TTM
$6.54
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$1,732,000,000
Inventory
$18,007,000,000
Receivables
$13,648,000,000
ST Investments
EBIT TTM
$2,347,000,000
Pretax Income TTM
$2,004,000,000
Interest Exp TTM
$343,000,000
Analysts
15

Yahoo Snapshot (yfinance, live)

Total Revenue
$250,735,001,600
EBITDA
$3,993,999,872
Free Cash Flow
$4,849,999,872
Enterprise Value
$58,751,062,016
Total Cash
$3,936,999,936
Total Debt
$8,915,999,744
Shares Out
234,205,855
Trailing EPS
$6.55
Book Value
$-12.05
ROE
ROA
3.6%
Div Yield
0.89%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Jun 2025 222,578,000,000 2,322,000,000 1,561,000,000 53,122,000,000 55,756,000,000 2,397,000,000
Jun 2024 226,827,000,000 2,130,000,000 852,000,000 45,121,000,000 48,333,000,000 3,762,000,000
Jun 2023 204,979,000,000 1,789,000,000 330,000,000 43,349,000,000 46,306,000,000 2,844,000,000
Jun 2022 181,326,000,000 1,648,000,000 -938,000,000 43,878,000,000 44,584,000,000 3,175,000,000

TTM Snapshot

Revenues TTM
$206,076,000,000
NetIncome TTM
$1,055,000,000
OpCashFlow TTM
$0
Assets (Latest)
$53,122,000,000
Forward EPS
$12.00

Max Pain — expiry 2027-01-15

max pain strike: $195.00 · spot: $235.63 · call oi: 6,525 · put oi: 5,673
Expected Move to 2027-01-15: ±$61.15 (25.95%) — implied range $174.48$296.78 · ATM straddle on $240.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
COR Cencora, Inc. $54.69B $281.10
TEL TE Connectivity plc $59.27B $203.05
GWW W.W. GRAINGER, INC. $62.34B $1320.48
FERG Ferguson Enterprises Inc. /DE/ $45.39B $234.05
SYY SYSCO CORP $37.91B $79.28

News headlines (Yahoo Finance, 1h cache)

[Latest] Global Neonatal Intensive Care Respiratory Devices Market Size/Share Worth USD 5.7 Billion by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast
2026-06-24 13:30 · Yahoo
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
2026-06-23 23:53 · Yahoo
Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals
2026-06-20 20:08 · Yahoo
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
2026-06-19 17:10 · Yahoo
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
2026-06-19 12:36 · Yahoo
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
2026-06-18 22:00 · Yahoo
Global Closed System Drug Transfer Devices Market Size/Share Worth USD 3.21 Billion by 2035 at a 8.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, G
2026-06-18 17:30 · Yahoo
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
2026-06-18 16:49 · Yahoo
Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?
2026-06-18 13:30 · Yahoo
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
2026-06-18 13:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.